Mineralys Therapeutics Inc. (MLYS)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
RA Capital Management

Peter Kolchinsky

7,692,750 $207,550,395 1.8%
2.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

5,871,018 $158,400,066 13.01%
3.
Deerfield Management

James E. Flynn

3,958,000 $106,786,840 1.11%
4. 2,506,152 $67,615,981 +13% 1.73%
5.
OrbiMed Advisors

Samuel Isaly

2,110,300 $56,935,894 +3% 1.05%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$24.16 58,300 $1,408,528.00 5,825,521 2026-03-30 Filing
$23.67 310,700 $7,354,269.00 5,767,221 2026-03-27 Filing
$25.50 588,235 $14,999,992.50 588,235 2025-09-04 Filing
$25.50 1,176,470 $29,999,985.00 5,456,521 2025-09-04 Filing
$13.50 259,259 $3,499,996.50 8,903,838 2025-03-13 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$25.46 75,000 $1,909,665.00 528,621 2026-09-30 Filing
$28.81 104,320 $3,005,302.72 7,805,718 2026-09-22 Filing
$28.12 7,438 $209,135.73 38,400 2026-09-21 Filing
$28.58 3,000 $85,740.00 6,200 2026-09-15 Filing
$25.98 7,437 $193,188.72 38,400 2026-08-21 Filing
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
No. Name Shares Value % Port
1. 100,869 $2,534,838 0.48%
2. 70,585 $1,773,801 0.05%
3. 925 $23,245 0%
4. 593 $14,902 0%
5. 224 $5,629 0%
News See All